Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€8.75

€8.75

-0.340%
-0.03
-0.340%
-
 
09:05 / Tradegate WKN: BEAU1Y / Name: Douglas / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Douglas AG Stock

Douglas AG shows a slight decrease today, losing -€0.030 (-0.340%) compared to yesterday.
For the coming years our community has positive and negative things to say abot the Douglas AG stock. Criterium "Business model" gathered the most positive votes but regarding "Growth compared to competition" there were negative voices in the community.

Pros and Cons of Douglas AG in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

United Natural Foods Q3 Earnings Call Highlights
United Natural Foods Q3 Earnings Call Highlights

Key Points

Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout
Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout

Annexon (NASDAQ:ANNX) executives outlined a series of expected clinical and regulatory updates across the company’s complement-focused pipeline during a session at the Jefferies Conference

Smiths Group Q3 Earnings Call Highlights
Smiths Group Q3 Earnings Call Highlights

Key Points